Coronary Stenosis Detection by 16-Slice Computed Tomography in Heart Transplant Patients Comparison With Conventional Angiography and Impact on Clinical Management by Romeo, Guido et al.
C
C
C
a
G
J
L
C
l
T
a
t
s
a
(
e
t
o
p
p
C
f
C
h
f
a
s
o
2
Journal of the American College of Cardiology Vol. 45, No. 11, 2005
© 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00
Poronary Stenosis Detection by 16-Slice
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nd Impact on Clinical Management
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OBJECTIVES We sought to find a non-invasive alternative to conventional coronary angiography (CCA)
for serial detection and follow-up of coronary stenosis due to cardiac allograft vasculopathy in
heart transplant patients.
BACKGROUND Cardiac allograft vasculopathy is the main factor limiting long-term success of heart
transplantation. It is usually detected by CCA. Multislice computed tomography (MSCT)
coronary angiography has recently proven effective for the diagnosis of coronary stenosis in
non-transplant patients.
METHODS Fifty-three consecutive heart transplant patients underwent MSCT within 24 h before or
after their annual routine CCA. Only angiographic segments 1.5 mm were considered for
analysis; the coronary arterial tree was divided into nine segments. Three patients were
excluded because of technical failure.
RESULTS Of the 450 angiographic coronary segments, 432 (96%) were evaluable by MSCT. Of the
nine coronary stents in seven patients, only three, including one intrastent restenosis, were
correctly evaluated by MSCT, and two intrastent restenoses were missed. Complete analysis
of the coronary tree was possible for 44 (88%) of the 50 patients. For detection of coronary
stenosis 50%, sensitivity was 83%, specificity 95%, positive predictive value 71%, negative
predictive value 95%, and accuracy 93%. In the 22 patients with strictly normal MSCT, no
stenosis was found by CCA.
CONCLUSIONS Our study suggests the following guidelines already applied in our institution: 16-slice MSCT
can replace CCA in de novo heart transplant patients and patients with strictly normal
MSCT at follow-up. Significant wall or lumen changes observed on annual MSCT or stents
require further investigation by CCA. (J Am Coll Cardiol 2005;45:1826–31) © 2005 by
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.02.069the American College of Cardiology Foundation
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wardiac allograft vasculopathy (CAV) is the main factor
imiting the long-term success of heart transplantation (1).
he prevalence of CAV assessed by conventional coronary
ngiography (CCA) ranges from 7.9% one year after heart
ransplantation to 43% after seven years (2). It is a progres-
ive and usually extensive disease involving both epicardial
nd small coronary vessels. Its origin is mostly immunologic
immune-mediated endothelial injury), but it may be influ-
nced by non-immunologic factors, such as systemic hyper-
ension, diabetes, and lipid disorders (1,3,4). It occurs most
ften without any ischemic symptoms, because the heart is
artially denervated. Its progression in heart transplant
atients can be very rapid, and the first manifestation of
AV can therefore be sudden death, congestive heart
ailure, or cardiac arrhythmia. Because of the silent nature of
AV, the rule is to perform annual screening for CAV in
eart transplant patients. Currently available noninvasive
unctional tests (e.g., treadmill test, thallium scintigraphy,
nd dobutamine stress echocardiography) lack adequate
ensitivity and specificity to predict either CAV or clinical
utcome in heart transplant patients (5–8). For these
From the Hopital Marie-Lannelongue, Le Plessis-Robinson, France.t
Manuscript received December 23, 2004; revised manuscript received February 4,
005, accepted February 8, 2005.easons, routine CCA remains the gold standard for diag-
osis and follow-up of CAV. Intravascular ultrasound
IVUS) has recently been recognized as the most sensitive
iagnostic tool for early detection of CAV, but remains an
nvasive technique (1,9), thus preventing its widespread use.
New multislice computed tomography (MSCT) technol-
gy allows direct non-invasive visualization of the anatomy
f coronary vessels, including the vessel wall and lumen
10–13).
The aim of this study was to assess the efficacy of MSCT
or the detection of significant focal stenosis in heart
ransplant patients, using CCA as the reference method.
ETHODS
atients. Between April 2003 and July 2004, 53 consecu-
ive heart transplant patients underwent 16-slice CT within
he 24 h before or after their annual routine CCA. Exclu-
ion criteria were severe renal insufficiency (blood creatinine
250 mol/l), severe cardiac insufficiency, or an unstable
linical condition. Patients with a previous allergic reaction
o iodinated contrast media received anti-allergic therapy for
he three days preceding the examination. All patients gave
ritten, informed consent, and the protocol had institu-ional review board approval. All patients were studied once.
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June 7, 2005:1826–31 16-Slice CT Scan in Heart Transplant Patientshe clinical characteristics of the patients are summarized in
able 1. The mean post-transplant time was 7.6 3.8 years
range 1 to 14.5 years). The mean age was 48  19 years
range 7.6 to 75 years). There were 40 men and 13 women.
ll patients received the same immunosuppressive regimen
f cyclosporine, mycophenolate mofetil, and corticoids.
SCT technique. All examinations were performed with
Siemens Sensation 16-slice CT (Siemens AG, Erlangen,
ermany). Oral beta-blockers (metoprolol 100 mg) were
dministered to all patients 1 h before MSCT to obtain a
esting heart rate70 beats/min. No sedation was required.
he standard acquisition protocol included a 420-ms rota-
ion time, a 0.75-mm slice thickness, and a 70 to 90 ml
njection of iodine contrast medium (concentration 370
g/ml) (iopamidol, Schering S.A., Berlin, Germany). The
ow rate was 3.5 ml/s. The images were acquired using 120
V and 500 mAs in normal weight patients. Parameters
ere adapted for light or overweight patients.
A first set of images was reconstructed systematically at
400 ms before the QRS complex, using a 1-mm slice
hickness and a 0.8-mm increment per slice, with a smooth
ernel and mediastinum windows. Additional reconstruc-
ions were performed in the presence of coronary stents,
ubstantial calcifications, or heart motion artifacts, or if
mages were excessively noisy. In cases of heart motion
rtifacts, additional sets of images were created for various
oints of the cardiac cycle, and the data set with the least
otion artifact was selected for further analysis.
Even if a cross-sectional image of the coronary artery
ould be easily obtained, spatial resolution with 16-slice CT
s insufficient for reliable quantitative measurements in diseased
reas. Therefore, as in other studies (10,13), coronary wall
hickening and stenosis were assessed visually by an experi-
nced observer blind to the CCA findings. The visual assess-
ents of coronary anatomy were graded on a three-step
everity scale: N  normal; WT  wall thickening without
ignificant stenosis (calcified or non-calcified plaque re-
Abbreviations and Acronyms
CAV  cardiac allograft vasculopathy
CCA  conventional coronary angiography
ISR  intrastent restenosis
IVUS  intravascular ultrasound
LAD  left anterior descending coronary artery
MSCT  multislice computed tomography
NPV  negative predictive value
PPV  positive predictive value
able 1. Clinical Characteristics of the Patients
Years
After HT No. of Patients
Age at HT
(yrs) No. of Stents
1–5 12 44.5  17.5 0
5–10 20 36  21 3
10–15 18 41.5  18 6eT  heart transplantation.tricting the lumen of 50% in diameter); S  stenosis
50%) or occlusion. Calcifications were rare in this pop-
lation, often small and localized, and did not impair visual
ssessment of coronary lesions. Only vessels 1.5 mm in
iameter were considered for MSCT evaluation. Each
oronary tree was divided into nine main coronary segments
or analysis: left main artery, left anterior descending (LAD)
rtery (proximal, middle, and distal), left circumflex artery
proximal and distal), right coronary artery (first, second,
nd third segments). The first and second diagonal branches
ere considered to be parts of the middle and distal LAD,
espectively. The first and second marginal branches were
onsidered to be parts of the distal circumflex artery.
CA. Coronary angiography was performed according to
tandard technique, using 4- or 5-F catheters. Coronary
all thickening was defined as an arterial wall irregularity or
oss of concentric profile of the vessel without significant
tenosis (50% in diameter). The degree of stenosis was
valuated visually by two experienced operators and scored
sing the scale described earlier.
The status of each of the nine coronary segments for each
atient, as assessed by MSCT, was compared with the
ndings by CCA used as the reference standard. Sensitivity,
pecificity, negative predictive value (NPV), and positive
redictive value (PPV) were calculated for detection of
ignificant stenosis by MSCT.
ESULTS
he MSCT imaging was performed without complications
n all patients. The duration of MSCT did not exceed 20 s.
he mean heart rate before the administration of metopro-
ol was 83  13 beats/min and fell to 69.5  11 beats/min
range 43 to 95 beats/min) at the time of MSCT. The entire
ine-segment coronary tree was successfully visualized by
SCT in 50 of 53 of the heart transplant patients (a total
f 450 coronary arterial segments). In three patients, the
oronary arteries could not be correctly evaluated because of
echnical failure, due to the patient being unable to hold
heir breath (n  2) or irregular heart rhythm (n  1).
hese three patients were excluded from further evaluation.
ighteen segments 1.5 mm in six patients could not be
orrectly analyzed, including six of nine stents. Visualization
as thus satisfactory in 432 (96%) of 450 segments, and
omplete analysis of the coronary arterial tree was possible
or 44 (88%) of 50 patients. Calcifications were detected by
SCT in 15 (30%) of the 50 patients. They were limited to
mall, calcified, parietal nodules in 13 patients and did not
mpair visual assessment of coronary lesions. Only two patients
ad heavy calcifications impairing coronary analysis.
nalysis by coronary segments. The results of the analysis
y coronary segments are detailed in Table 2.
ORMAL SEGMENTS. There were 314 of 432 segments
cored as normal by MSCT analysis. All segments identified
s normal by MSCT were also found to be normal with CCA,
xcept for seven segments scored as thickened by CCA.
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16-Slice CT Scan in Heart Transplant Patients June 7, 2005:1826–31ALL THICKENING ASSESSMENT. A total of 108 coronary
egments were scored as thickened by MSCT, whereas only
0 were by CCA (p  0.000 by the Fischer exact test): 55
f the 108 segments considered as thickened by MSCT
ere considered normal by CCA. These 55 discordant
ndings were only in five patients. Two segments consid-
red as thickened by MSCT were found to have significant
tenosis with CCA (one proximal LAD and one first
arginal branch).
TENOSIS DETECTION. Significant stenosis was diagnosed
y MSCT in 10 segments, but only eight of them were
onsidered as stenotic by CCA. Two segments in the
iddle and distal LAD, considered as having significant
tenosis by MSCT, were only scored as thickened on CCA.
hese two segments were not assessed by physiologic
esting. Ten significant stenoses (50% in diameter) were
iagnosed by CCA in six patients. Three were located in the
AD and seven in the circumflex artery. Two occurred
ithin a previously implanted intracoronary stent. Two
atients had multivessel disease, and in all the other pa-
ients, one single vessel was affected.
TENT EVALUATION. Nine stents were analyzed in seven
atients (two in the LAD, three in the diagonal branches,
wo in the circumflex artery, and two in the right coronary
rtery). Only three stents could be correctly evaluated by
SCT, including one intrastent restenosis (ISR) correctly
etected. In the other six cases, MSCT failed to analyze
ntrastent anatomy, and significant ISR was missed by
SCT in two stented segments, probably because of the
mall size of the stent and heart rate 70 beats/min.
ON-INTERPRETABLE SEGMENTS. Eighteen segments
ould not be correctly evaluated by MSCT, and they
ncluded six stents (with two cases of ISR missed). In the
emaining 12 segments, three stenoses and two wall thick-
nings located in coronary segments 1.5 mm were iden-
ified by CCA but not by MSCT.
nalysis by patients. Results of analyses by patients are
etailed in Table 3.
ATIENTS WITH NORMAL CORONARY ARTERIES (FIG. 1). In
he 22 patients with completely normal MSCT, no stenosis
as found by CCA, and 20 (91%) of 22 also had strictly
ormal CCA. Two patients had normal MSCT, but wall
hickening without significant stenosis was detected by CCA.
ALL THICKENING ASSESSMENT (FIG. 2). In 15 patients
able 2. Analysis by Coronary Segments
MSCT/CCA N WT S Total
N 307 7 0 314
WT 55 51 2 108
S 0 2 8 10
Total 362 60 10 432
CA  conventional coronary angiography; MSCT  multislice computed tomog-
aphy; N  normal; S  stenosis; WT  wall thickening.ith wall thickening detected by MSCT, one stenosis Aonsidered as significant by CCA was missed in a distal
ircumflex artery 1.5 mm, and in five, CCA revealed
ormal coronary arteries. Among the six patients with
ncomplete MSCT analysis (not included in Table 2), one
dditional stenosis was missed. One case of wall thickening
non-calcified plaque, Fig. 1) was diffuse (several centime-
ers) and regular, and for this reason, it was not classified as
tenosis by MSCT or CCA.
TENOSIS DETECTION (FIG. 3). Among the seven patients
aving at least one50% stenosis detected by MSCT (both
n cross section and multiple views of the vessel), CCA
iagnosed only wall thickening and no stenosis in two (two
alse-positives, located in the middle and distal LAD).
hysiologic testing was not performed in these two cases.
ne significant stenosis detected by CCA in the distal left
osterior descending artery was wrongly considered as wall
hickening by MSCT (one false-negative). This last stenosis
as not amenable to intervention.
For the 44 patients in whom coronary arteries could be
valuated by MSCT, the overall sensitivity of MSCT for
etection of stenosis was 83%, specificity 95%, PPV 71%,
PV 95%, and accuracy 93%.
ISCUSSION
lthough considerable progress has been made in the
voidance of early acute rejection, due to the recent emer-
ence of new immunosuppressive agents, including myco-
henolate mofetil, no real preventive treatment against
AV has been available until recently. Still, CAV remains
he inevitable stumbling block of heart transplantation, and
he only effective treatment is retransplantation. However,
fforts are continuing to improve early detection of the
isease, with the hope that palliative treatments such as
oronary angioplasty with or without the use of stents could
ncrease the survival of the graft. This assumption is
ncreasingly disputed (14), and the clinical utility of routine
oronary angiography, still used in most centers including
urs, has been questioned (15,16).
However, the recent clinical evaluations of molecular
arget of rapamycin inhibitors (sirolimus and everolimus)
rovide a new hope. These drugs could, for the first time
ince heart transplantation has been used, prevent CAV,
low its progression, and even (one case reported with
irolimus) allow regression of coronary lesions (17). Everoli-
us, administered in association with cyclosporine, seems
able 3. Analysis by Patients
MSCT/CCA N WT S Total
N 20 2 0 22
WT 5 9 1 15
S 0 2 5 7
Total 25 13 6 44bbreviations as in Table 2.
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June 7, 2005:1826–31 16-Slice CT Scan in Heart Transplant Patientsarticularly promising (18). If these preliminary results are
onfirmed, the widespread use of these new immunosup-
ressors will renew the importance of early detection of
AV to allow appropriate medical treatment. In this con-
ext, a reliable and noninvasive method of detection is
equired. Conventional coronary angiography has been
roven to underestimate the severity of CAV, because these
esions particular to heart transplant patients develop in a
oncentric fashion, mimicking normal coronary arteries
uring the early phase. It is an invasive technique and
nevitably involves some degree of risk. In addition, routine
igure 1. (A) Multislice computed tomography: normal aspect of the
roximal left and right coronary arteries. Note some partial volume effect in
he proximal right coronary artery (RCA). (B) Same patient, with conven-
ional coronary angiography: normal aspect of the proximal left and right
oronary arteries. Ao aorta; Cx circumflex artery; LAD left anterior
escending artery.nnual CCA is perceived as uncomfortable and psycholog-cally painful to heart transplant patients. It is now recog-
ized that the long-term success of heart transplantation
argely depends on the patient’s compliance with a treat-
ent and follow-up regimen (19). Any opportunity to
lleviate the burden on these patients must be seized.
Here, we demonstrate that MSCT can provide an accu-
ate, non-invasive evaluation of CAV by showing coronary
all thickening and by detecting significant coronary ste-
osis in heart transplant patients.
igure 2. (A) Multislice computed tomography: diffuse wall thickening of
he left main coronary artery and left anterior descending (LAD) artery,
ith some calcifications limited to small, calcified, parietal nodules (white
rrows) and non-calcified plaques (black arrows). Note some irregularity
f the proximal LAD and diffuse narrowing of the distal LAD. There was
o significant coronary stenosis. (B) Same patient, with conventional
oronary angiography: normal aspect of the circumflex artery (Cx); diffuse
all thickening of the LAD was seen as diffuse narrowing of the coronary
umen. Ao  aorta.Because CCA shows only luminal changes, without
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16-Slice CT Scan in Heart Transplant Patients June 7, 2005:1826–31irect visualization of the arterial wall, early assessment of
ural changes induced by this vasculopathy is limited. In
ddition, CAV is typically a diffuse phenomenon, which
ay be difficult to detect during the early phase. Several
tudies report that CCA is less sensitive than IVUS studies
o detect wall thickening (20).
Multislice CT could be more appropriate than CCA for
his kind of evaluation, by showing both mural and luminal
oronary changes associated with this vasculopathy. Our
tudy suggests that MSCT may be more sensitive than
CA for detection of thickened segments (108 vs. 60)
igure 3. (A) Multislice computed tomography: severe stenosis of the first
egment of the circumflex artery (Cx) associated with distal stenosis in the
ircumflex artery (arrows). (B) Same patient, with conventional coronary
ngiography: severe stenosis of the first segment of the circumflex artery
ssociated with distal stenosis in the circumflex artery (arrows). Ao 
orta; LAD  left anterior descending artery.Table 2). bHowever, for ethical and also practical reasons, we did
ot compare MSCT findings to IVUS. The aim of this
tudy was not to evaluate wall thickening but to investigate
ow to detect and above all not miss coronary stenosis in
his particular population. However, only 51 (85%) of 60
egments considered as thickened by CCA were also found
hickened by MSCT. Wall changes were assessed visually by
ne experienced radiologist, using cross-sectional views of
he artery to ensure a concentric gray area surrounding the
all lumen, opacified with contrast medium. Most of these
ndings were unambiguous (Fig. 1), but minor wall changes
ay be missed. Recent reports showed that MSCT is
aluable for detecting atherosclerotic plaques and that the
ndings correlate well with those by IVUS (11,12). Multi-
lice CT is thus a promising technique for coronary wall
valuation.
Three hundred and seven (71%) of 432 segments, includ-
ng two stented segments, were considered as normal by
SCT, none of them being stenotic by CCA, and none of
he 22 patients with normal coronaries, as assessed by
SCT, had coronary stenosis, as assessed by CCA. This
epresents the main point of interest of our study for clinical
anagement of heart transplant patients: the NPV was high
95%). This high NPV is comparable to that observed in
oronary atherosclerosis (10,13). A normal MSCT in this
linical setting may make subsequent annual CCA unnec-
ssary. This was the secondary aim of this study: to find a
oninvasive technique to replace CCA.
In the subgroup of 15 patients with wall thickening but
o significant stenosis detected by MSCT, two stenoses
ere missed in the same patient. Because the spatial
esolution of MSCT is lower than that of CCA, detection
f stenosis may be more difficult in thickened segments,
ecause the artery lumen is already smaller in a diffuse
ashion. Such findings in heart transplant patients should
ead to careful analysis before excluding significant narrow-
ng, and in some cases, CCA may be required for confir-
ation.
Eight stenoses were correctly diagnosed by MSCT in 10
valuable segments, but three were missed in non-evaluable
essels 1.5 mm. In addition, two cases of ISR were
issed. Intrastent analysis was not reliable with 16-slice
T, because only three (33%) of nine of the stents could be
orrectly visualized. Our study clearly indicates that the only
eliable tool for detection of ISR at the present time remains
CA.
tudy limitations. The main limitation of this study con-
erns the size of the vessels, which must be 1.5 mm in
iameter to be correctly evaluated. Three stenoses were
issed in vessels 1.5 mm. However, these stenoses would
ot have been accessible to percutaneous angioplasty be-
ause of the small size of the vessel.
Another limitation is that the heart rate must be 70
eats/min, which is rarely the case in this population.
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June 7, 2005:1826–31 16-Slice CT Scan in Heart Transplant Patientsardiac re-innervation is highly variable in heart transplant
atients, and the efficacy of beta-blockers is also, conse-
uently, variable and often limited. However, the mean
eart rate decreased from 83 to 69.5 beats/min after oral
dministration of metoprolol, permitting good-quality im-
ges in the majority of our patients.
The requirement for an experienced observer for MSCT
nalysis, because of the necessity of visual assessment of wall
hickening and stenosis, is another limiting factor. Coronary
alcifications often impair assessment of stenosis by MSCT
n atherosclerotic patients (13), but the calcifications ob-
erved in our population of heart transplant patients were of a
ifferent nature and hindered the analysis in only two cases.
The radiation dose is a real problem in this population.
hese patients are exposed to repeated examinations. How-
ver, in our institution, we systematically use an electrocar-
iographic pulsing technique to reduce the radiation dose
uring systole, allowing a reduction of up to 40% of the
adiation dose (21). We also apply individual adaptation
ccording to the patient’s morphology. Due to these adap-
ations, the radiation doses used are 3 to 8 mSv, in the same
ange as CCA.
Patients with moderate renal insufficiency were hydrated
fter MSCT, and creatinine did not increase.
onclusions. Our study provides information on the po-
ential of MSCT for non-invasive follow-up of heart trans-
lant patients. Our results suggest the following guidelines,
hich are already applied in our institution:
. Multislice CT can replace CCA for annual screening of
coronary stenosis in de novo heart transplant patients.
. For other transplant patients, a strictly normal MSCT
at follow-up indicates that subsequent CCA is not
necessary.
. Patients with coronary wall thickening on MSCT
should be closely monitored, and CCA could be pro-
posed on a case-by-case basis.
. Patients with coronary stenosis detected by MSCT
must undergo CCA to confirm the stenosis and, if
necessary, undergo angioplasty.
. Patients with stents are not eligible for MSCT and
require CCA.
These preliminary results are sufficiently encouraging to
ave modified our protocol for annual screening of CAV in
eart transplant patients. In the near future, the expected
mprovements in MSCT technology may allow a better
nalysis of coronary lesions and ISR. Further evaluation is
arranted to confirm that the guidelines we propose herein
re clinically appropriate.
eprint requests and correspondence: Dr. Lucile Houyel, Hôpi-
al Marie-Lannelongue, 133 Avenue De La Résistance, 92350 Le
lessis-Robinson, France. E-mail: Houyel@ccml.com.EFERENCES
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